Alcarb 450 Injection
Marketer
Axiommax Oncology Pvt Ltd
Salt Composition
Carboplatin (450mg)
Overview Alcarb 450 Injection
Carbosyn 450 Injection treats ovarian and small-cell lung cancers by inhibiting or reducing cancer cell proliferation. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. The medication can decrease blood cell counts, raising infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding or bruising, and dark urine immediately. Regular blood tests monitoring blood cell levels, heart, liver function, and uric acid are essential. Report any allergic reactions like skin rash, itching, or breathing difficulties. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is vital for both partners throughout treatment.
Primary Ingredients of Alcarb 450 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Alcarb 450 Injection
Cancers of the ovary and small-cell lung
Major Benefits of Alcarb 450 Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Alcarb 450 Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Alcarb 450 Injection:
The medication will be administered by your physician or their assistant; self-medication is strictly prohibited.
How Alcarb 450 Injection works:
Onco-450 injection is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Alcarb 450 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Alcarb 450 Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Alcarb 450 Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingUNSAFE
Administering Alcarb 450 Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Individuals with kidney impairment should use Alcarb 450 Injection cautiously, potentially requiring a modified dosage. Physician consultation is recommended. Alcarb 450 Injection is contraindicated in patients with severe kidney dysfunction. Routine monitoring of renal function is advisable during treatment.
LiverSAFE IF PRESCRIBED
The use of Alcarb 450 Injection in patients with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Alcarb 450 Injection :
Omit a dose of Alcarb 450 Injection? Seek your physician's advice.
Facts to Know About Alcarb 450 Injection
| Label | Value |
|---|---|
| Pharmaceutical Classification | Platinum-based compounds |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Platinum-based anti-cancer agents |
3,018 People bought this recently